Call for Paper - Upcoming Issues

A Study of Clinical Profile, Risk Factors and Outcome in Patients of Cerebral Venous Sinus Thrombosis

International Journal of Medical Science
© 2016 by SSRG - IJMS Journal
Volume 3 Issue 12
Year of Publication : 2016
Authors : Kapinder Yadav, Surekha Dabla, Bhuwan Sharma, Preeti Yadav, Surender Kumar and Himanshu Juneja
10.14445/23939117/IJMS-V3I12P103
pdf
How to Cite?

Kapinder Yadav, Surekha Dabla, Bhuwan Sharma, Preeti Yadav, Surender Kumar and Himanshu Juneja, "A Study of Clinical Profile, Risk Factors and Outcome in Patients of Cerebral Venous Sinus Thrombosis," SSRG International Journal of Medical Science, vol. 3,  no. 12, pp. 14-17, 2016. Crossref, https://doi.org/10.14445/23939117/IJMS-V3I12P103

Abstract:

Cerebral venous sinus thrombosis (CVST) is an uncommon cause of stroke with extremely varied clinical features, predisposing factors and outcomes. With the widespread use of neuroimaging and hematological work up more and more patients are being confidently diagnosed.

Keywords:

 To study the clinical profile, risk factors, radiological findings and outcome in patients of CVST at tertiary care center in Haryana.

References:

[1] Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol 2007; 6:162–70.
[2] Bousser MG, Chiras J, Bories J, Castagne P. Cerebral venous thrombosis: A review of 38 cases. Stroke 1985; 16:199–213.
[3] Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).  Stroke 2004; 35:664-70.
[4] De Bruijn SFTM, de Haan RJ, Stam J. Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. J Neurol Neurosurg Psychiatry 2001; 70:105–8.
[5] Deschiens M, Conard J, Horellou M, Ameri A, Preter M, Chedu F. Coagulation studies, factor V Leiden and anticardiolipin antibodies in 40 cases of cerebral venous sinus thrombosis. Stroke 1996; 27:1724–30.
[6] Nagaraja D, Sarma GR. Treatment of cerebral sinus/venous thrombosis. Neurol  India 2002; 50:114 
[7] Nagpal RD.  Dural sinus and cerebral venous thrombosis. Neurosurg Review 1983; 6:155-60.
[8] Bansal BC, Gupta RR, Prakash C. Stroke during pregnancy and puerperium in young females below the age of 40 years as a result of cerebral venous/venous sinus thrombosis. Jpn Heart J 1980; 21:171-83.
[9] Cantu C, Alonso E, Jara A, Martinez L, Rios C, Fernandez MA et al. Hyperhomocysteinemia, low Folate and vitamin B12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke 2004; 35:1790-94.
[10] Daif A, Awada A, Al-Rajeh S, Abduljabbar M, Al Tahan AR, Obeid T. Cerebral venous thrombosis in adults. A study of 40 cases from Saudi Arabia. Stroke 1995; 26:1193–95.
[11] Narayan D, Kaul S, Ravishankar K, Suryaprabha T, Bandaru VS, Mridula KR, et al.           Risk factors, clinical profile, and long-term outcome of 428 patients of cerebral sinus venous thrombosis. Neurol India 2012; 60:154-59.